StockWatch
·
Pharmaceuticals
Rights Issue31 Jul 2026, 05:50 pm

Natural Biogenex Approves Right Issue Allotment of 9.46 Lakh Shares

AI Summary

Natural Capsules Ltd's material unlisted subsidiary, Natural Biogenex Private Limited, has approved the allotment of 9,46,305 equity shares through a Rights Issue. This allotment, valued at ₹94,63,050, was approved at a Board Meeting held on July 31, 2026, following an initial approval on July 10, 2026. The shares have a face value of ₹10 each and are issued for cash at par.

Key Highlights

  • Subsidiary approved allotment of 9,46,305 equity shares.
  • Rights Issue valued at ₹94,63,050.
  • Allotment approved on July 31, 2026.
  • Shares issued for cash at par with face value of ₹10.